Figure 1From: Gene signatures of breast cancer progression and metastasisCorrelating molecular and clinical characteristics can address the multiple aspects of biological, clonal and patient heterogeneity in breast cancer metastasis and lead to gene profiles, commercial assays and clinical trials that ultimately result in clinical applications to improve prognostic accuracy and treatment outcome for individual patients.Back to article page